TITLE

Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases

AUTHOR(S)
Eun, Chang Soo; Han, Dong Soo; Park, Joon Yong; Jeon, Yong Cheol; Hahm, Joon Soo; Kim, Kyung Suk; Kang, Jung Oak
PUB. DATE
May 2003
SOURCE
Journal of Gastroenterology;2003, Vol. 38 Issue 5, p436
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Antibiotic resistance of Helicobacter pylori is problematic because it reduces the efficacy of eradication therapy. It has been suggested that the incidence of resistance is rising. In Korea, information on the antimicrobial resistance of H. pylori is rare. The aim of this study was to assess the prevalence of H. pylori antibiotic resistance at a single center in Korea, and the changes in its antimicrobial resistance, and to detect the mutation foci of clarithromycin-resistant strains. Methods. H. pyloriisolates obtained from 224 patients with peptic ulcer disease in Korea between June 1996 and March 2000 were tested for antimicrobial resistance. The minimum inhibitory concentration (MIC) for metronidazole and clarithromycin was determined by the broth microdilution method. Isolates were considered resistant when the MIC was more than 8 μg/ml for metronidazole and more than 1 μg/ml for clarithromycin. To detect H. pylori 23S rRNA mutations, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed. Sequencing was performed on the two strands of the nonrestricted amplicons. Results. Overall, resistance to metronidazole and clarithromycin was detected in 41.9% and 5.4% of patients, respectively. There was no significant difference in metronidazole and clarithromycin resistance according to age group and sex. Six strains were resistant to both metronidazole and clarithromycin. Six of nine clarithromycin-resistant isolates possessed the A2144G mutation in the gene encoding 23S rRNA. Sequencing of the three non-restricted clarithromycin-resistant strains revealed a T-to-C mutation at position 2182. Conclusions. In Korea, there was no significant increase in the prevalence of metronidazole resistance, but clarithromycin-resistant H. pylori strains had increased relatively over the 5-year period. There was an increasing tendency for the emergence of strains with dual resistance to metronidazole and clarithromycin....
ACCESSION #
9872769

 

Related Articles

  • Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. Cuadrado-Lavín, Antonio; Salcines-Caviedes, J. Ramón; Carrascosa, Miguel F.; Mellado, Purificación; Monteagudo, Idoia; Llorca, Javier; Cobo, Marta; Campos, M. Rosario; Ayestarán, Blanca; Fernández-Pousa, Antonio; González-Colominas, Elena // Journal of Antimicrobial Chemotherapy (JAC);Jan2012, Vol. 67 Issue 1, p170 

    Background Antibiotic resistance is directly related to the loss of efficacy of currently accepted Helicobacter pylori therapies. Knowledge of the antibiotic susceptibility in a local area can contribute to the design of specific ‘à la carte’ treatments. The aim of this study was...

  • Causes of failure of eradication of Helicobacter pylori. Jenks, Peter J // BMJ: British Medical Journal (International Edition);7/6/2002, Vol. 325 Issue 7354, p3 

    Editorial. Comments on the importance of eradication of Helicobacter pylori from the gastric and duodenal mucosa of infected patients for the management of peptic ulcer disease and other conditions associated with H. pylori. Discussion of antibiotic resistance as the major cause of failure to...

  • Stress and diet do not cause ulcers, bacteria does.  // Executive Health's Good Health Report;Nov95, Vol. 32 Issue 2, p2 

    Explains that the Helicobacter pylori bacterium causes peptic ulcers, and not stress or diet, as believed by most Americans with digestive disorders. Three causes of ulcers; Description of H. pylori; Treatment of H. pylori caused ulcers with antibiotics.

  • Peptic ulcer disease: Clinical options for detecting and eradicating H pylori infection. Lichtenstein, David R.; Rees, Michael K. // Modern Medicine;Dec94, Vol. 62 Issue 12, p41 

    Provides therapy for treating peptic ulcer disease. Etiology of peptic ulcer disease; Helicobacter pylori as main cause; Detection and treatment. INSET: Epidemiology and transmission..

  • Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Hawkey, C.J. // BMJ: British Medical Journal (International Edition);12/10/94, Vol. 309 Issue 6968, p1570 

    Examines the eradication of Helicobacter pylori in managing peptic ulceration. Relapse of gastric and duodernal ulcer after eradication; Causes of the ulcer diathesis; Prevention of the complications of ulcer.

  • Helicobacter pylori is not the causative agent. Record, C.O. // BMJ: British Medical Journal (International Edition);12/10/94, Vol. 309 Issue 6968, p1571 

    Examines the eradication of helicobacter pylori. Link between helicobacter pylori and peptic ulceration; Causes of diseases; Application of hydrogen receptor antagonist and antibiotics; Cost effectiveness of eradication.

  • A bleeding ulcer that just won't go away.  // Patient Care;12/15/1995, Vol. 29 Issue 20, p145 

    Presents a case of peptic ulcers with the presence of Helicobacter pylori infection. Test performed; Importance of diagnosing H. pylori infection and understanding its relationship to peptic ulcer disease; How H. pylori is identified.

  • Urease breath test for Helicobacter pylori infection. Kirchner, Jeffrey T. // American Family Physician;4/1/1998, Vol. 57 Issue 7, p1646 

    Presents a summary of the article `Breath test diagnosis of Helicobacter pylori in peptic ulcer disease: a noninvasive primary care option,' by M.W. Felz, from Journal of American Board Family Practice, dated November 1997.

  • Office-based H pylori eradication rates equal those seen in research.  // Geriatrics;Aug97, Vol. 52 Issue 8, p24 

    States that favorable eradication of helicobacter pylori demonstrated in clinical trials are equaled when patients with ulcer are treated in community settings. Opinion of co-investigator David A. Lieberman, professor of medicine, Oregon Health Sciences University about H pylori treatment; Most...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics